Skip to main content

Table 1 Characteristics of patient AML samples.

From: Microarray analysis reveals genetic pathways modulated by tipifarnib in acute myeloid leukemia

Patient Dose (mg) Age/sex Diagnosis Stage Antigen expression ras status
B 100 59 M M5, de novo AML Relapse CD34+, CD33+ WT
A 300 75 M M4, de novo AML New CD34+, CD33+ WT
  1. WT = wild-type